Literature DB >> 21894487

Nicotine self-administered directly into the VTA by rats is weakly reinforcing but has strong reinforcement enhancing properties.

Morag J Farquhar1, Mary P Latimer, Philip Winn.   

Abstract

RATIONALE: Rats will lever press to deliver nanolitre quantities of nicotine or the muscarinic agonist carbachol directly into the ventral tegmental area (VTA). The purpose of these experiments was to investigate further the characteristics of nicotine self-administration directly into the VTA.
OBJECTIVES: This study aimed to confirm previous data relating to intra-VTA self-administration of nicotine and carbachol and then test two hypotheses: (a) that pre-sensitisation of nicotinic receptors is needed for robust intra-VTA self administration and (b) that rats will lever press for intra-VTA nicotine if pre-trained to associate lever pressing with a rewarding outcome.
METHODS: Rats were equipped with cannulae aimed at posterior VTA and allowed five sessions to self-administer nicotine or carbachol. In different experiments, rats were either pre-sensitised to nicotine by subcutaneous (s.c.) injections or pre-trained to lever press for food and a simultaneous conditioned stimulus light.
RESULTS: We confirmed that carbachol had strong activating effects when self-administered into the VTA; selective responding for nicotine developed over five sessions by reduction in the amount of pressing on an inactive lever. Prior sensitisation did not improve responding for intra-VTA nicotine but training rats to lever press before putting them on the drug regime did potentiate pressing.
CONCLUSIONS: The action of nicotine in the VTA might be better considered as reinforcement enhancing and that its intrinsic rewarding property here is at best weak. Identification of the VTA as a target for the reinforcement enhancing effects of nicotine is compatible with the reinforcement-related functions of VTA dopamine neurons and their cholinergic inputs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21894487     DOI: 10.1007/s00213-011-2452-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  46 in total

1.  Self-administration enhances excitatory synaptic transmission in the bed nucleus of the stria terminalis.

Authors:  Eric C Dumont; Gregory P Mark; Sarah Mader; John T Williams
Journal:  Nat Neurosci       Date:  2005-02-27       Impact factor: 24.884

2.  Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area.

Authors:  Rubing Zhao-Shea; Liwang Liu; Lindsey G Soll; Ma Reina Improgo; Erin E Meyers; J Michael McIntosh; Sharon R Grady; Michael J Marks; Paul D Gardner; Andrew R Tapper
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

3.  6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine.

Authors:  J R Taylor; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Primary reinforcing effects of nicotine are triggered from multiple regions both inside and outside the ventral tegmental area.

Authors:  Satoshi Ikemoto; Mei Qin; Zhong-Hua Liu
Journal:  J Neurosci       Date:  2006-01-18       Impact factor: 6.167

5.  Laterodorsal tegmental projections to identified cell populations in the rat ventral tegmental area.

Authors:  Natalia Omelchenko; Susan R Sesack
Journal:  J Comp Neurol       Date:  2005-03-07       Impact factor: 3.215

6.  Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat.

Authors:  Gina L Forster; Charles D Blaha
Journal:  Eur J Neurosci       Date:  2003-02       Impact factor: 3.386

Review 7.  Cholinergic modulation of midbrain dopaminergic systems.

Authors:  J Mena-Segovia; P Winn; J P Bolam
Journal:  Brain Res Rev       Date:  2008-02-21

8.  Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats.

Authors:  Matthew I Palmatier; Melissa E Levin; Kara L Mays; Eric C Donny; Anthony R Caggiula; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2009-09-17       Impact factor: 4.530

9.  Voluntary nicotine consumption triggers in vivo potentiation of cortical excitatory drives to midbrain dopaminergic neurons.

Authors:  Stéphanie Caillé; Karine Guillem; Martine Cador; Olivier Manzoni; François Georges
Journal:  J Neurosci       Date:  2009-08-19       Impact factor: 6.167

10.  The effects of nicotine on locomotor activity in non-tolerant and tolerant rats.

Authors:  P B Clarke; R Kumar
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

View more
  4 in total

1.  Ethanol and nicotine interaction within the posterior ventral tegmental area in male and female alcohol-preferring rats: evidence of synergy and differential gene activation in the nucleus accumbens shell.

Authors:  William A Truitt; Sheketha R Hauser; Gerald A Deehan; Jamie E Toalston; Jessica A Wilden; Richard L Bell; William J McBride; Zachary A Rodd
Journal:  Psychopharmacology (Berl)       Date:  2014-08-26       Impact factor: 4.530

2.  Role of α5* nicotinic acetylcholine receptors in the effects of acute and chronic nicotine treatment on brain reward function in mice.

Authors:  Christie D Fowler; Luis Tuesta; Paul J Kenny
Journal:  Psychopharmacology (Berl)       Date:  2013-08-20       Impact factor: 4.530

Review 3.  Nicotine and alcohol: the role of midbrain dopaminergic neurons in drug reinforcement.

Authors:  Carole Morel; Sarah Montgomery; Ming-Hu Han
Journal:  Eur J Neurosci       Date:  2018-10-15       Impact factor: 3.386

Review 4.  Nicotine Acutely Enhances Reinforcement from Non-Drug Rewards in Humans.

Authors:  Kenneth A Perkins; Joshua L Karelitz; Margaret C Boldry
Journal:  Front Psychiatry       Date:  2017-05-01       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.